Modulators of microglia: a patent review

References

• Katsumoto A, Lu H, Miranda AS, et al. Ontogeny and functions of central nervous system macrophages. J Immunol. 2014;193:2615–2621.
   PubMed Web of Science ®Google Scholar
• Lawson LJ, Perry VH, Gordon S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience. 1992;48:405–415.
   PubMed Web of Science ®Google Scholar
• Ling EA, Wong WC. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia. 1993;7:9–18.
   PubMed Web of Science ®Google Scholar
• Jung S, Schwartz M. Non-identical twins - microglia and monocyte-derived macrophages in acute injury and autoimmune inflammation. Front Immunol. 2012;3:89.
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841–845.
   PubMed Web of Science ®Google Scholar
• Alliot F, Lecain E, Grima B, et al. Microglial progenitors with a high proliferative potential in the embryonic and adult mouse brain. Proc Natl Acad Sci U S A. 1991;88:1541–1545.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM, Cardona AE. The myeloid cells of the central nervous system parenchyma. Nature. 2010;468:253–262.
   PubMed Web of Science ®Google Scholar
• Kettenmann H, Hanisch UK, Noda M, et al. Physiology of microglia. Physiol Rev. 2011;91:461–553.
   PubMed Web of Science ®Google Scholar
• Glenn JA, Ward SA, Stone CR, et al. Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability. J Anat. 1992;180(Pt 1):109–118.
   PubMed Web of Science ®Google Scholar
• Kettenmann H, Kirchhoff F, Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron. 2013;77:10–18.
   PubMed Web of Science ®Google Scholar
• Tremblay ME, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010;8:e1000527.
   PubMed Web of Science ®Google Scholar
• Wake H, Moorhouse AJ, Jinno S, et al. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009;29:3974–3980.
   PubMed Web of Science ®Google Scholar
• Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596–1609.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Paolicelli RC, Sforazzini F, et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci. 2014;17:400–406.
   PubMed Web of Science ®Google Scholar
• Sierra A, Encinas JM, Deudero JJ, et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell. 2010;7:483–495.
   PubMed Web of Science ®Google Scholar
• Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691–705.
   PubMed Web of Science ®Google Scholar
• Schafer DP, Lehrman EK, Stevens B. The “quad-partite” synapse: microglia-synapse interactions in the developing and mature CNS. Glia. 2013;61:24–36.
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456–1458.
   PubMed Web of Science ®Google Scholar
• Michell-Robinson MA, Touil H, Healy LM, et al. Roles of microglia in brain development, tissue maintenance and repair. Brain. 2015;138:1138–1159.
   PubMed Web of Science ®Google Scholar
• Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol. 2014;32:367–402.
   PubMed Web of Science ®Google Scholar
• Hu X, Leak RK, Shi Y, et al. Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol. 2015;11:56–64.
   PubMed Web of Science ®Google Scholar
• Sica A, Invernizzi P, Mantovani A. Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology. 2014;59:2034–2042.
   PubMed Web of Science ®Google Scholar
• Kigerl KA, Gensel JC, Ankeny DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435–13444.
   PubMed Web of Science ®Google Scholar
• Franco R, Fernandez-Suarez D. Alternatively activated microglia and macrophages in the central nervous system. Prog Neurobiol. 2015;131:65–86.
   PubMed Web of Science ®Google Scholar
• David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12:388–399.
   PubMed Web of Science ®Google Scholar
• Shechter R, Schwartz M, Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer ‘if’ but ‘how’. J Pathol. 2013;229:332–346.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549–555.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677–686.
   PubMed Web of Science ®Google Scholar
• Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity. 1999;10:137–142.
   PubMed Web of Science ®Google Scholar
• Goerdt S, Politz O, Schledzewski K, et al. Alternative versus classical activation of macrophages. Pathobiology. 1999;67:222–226.
   PubMed Web of Science ®Google Scholar
• Schwartz M, Baruch K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. Embo J. 2014;33:7–22.
   PubMed Web of Science ®Google Scholar
• Frank-Cannon TC, Alto LT, McAlpine FE, et al. Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener. 2009;4:47.
   PubMed Web of Science ®Google Scholar
• Kawabori M, Yenari MA. The role of the microglia in acute CNS injury. Metab Brain Dis. 2015;30:381–392.
   PubMed Web of Science ®Google Scholar
• Zhou X, He X, Ren Y. Function of microglia and macrophages in secondary damage after spinal cord injury. Neural Regen Res. 2014;9:1787–1795.
   PubMed Web of Science ®Google Scholar
• Patel AR, Ritzel R, McCullough LD, et al. Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol. 2013;5:73–90.
   PubMedGoogle Scholar
• Brites D, Vaz AR. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci. 2014;8:117.
   PubMed Web of Science ®Google Scholar
• Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem Pharmacol. 2014;88:594–604.
   PubMed Web of Science ®Google Scholar
• Doorn KJ, Lucassen PJ, Boddeke HW, et al. Emerging roles of microglial activation and non-motor symptoms in Parkinson’s disease. Prog Neurobiol. 2012;98:222–238.
   PubMed Web of Science ®Google Scholar
• Vezzani A, Aronica E, Mazarati A, et al. Epilepsy and brain inflammation. Exp Neurol. 2013;244:11–21.
   PubMed Web of Science ®Google Scholar
• Bogie JF, Stinissen P, Hendriks JJ. Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathol. 2014;128:191–213.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem. 2005;280:40364–40374.
   PubMed Web of Science ®Google Scholar
• Frakes AE, Ferraiuolo L, Haidet-Phillips AM, et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009–1023.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Imagama S, Ohgomori T, et al. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis. 2013;4:e525.
   PubMed Web of Science ®Google Scholar
• Stirling DP, Cummins K, Mishra M, et al. Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury. Brain. 2014;137:707–723.
   PubMed Web of Science ®Google Scholar
• Pisanu A, Lecca D, Mulas G, et al. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson’s disease. Neurobiol Dis. 2014;71:280–291.
   PubMed Web of Science ®Google Scholar
• Yonutas HM, Sullivan PG. Targeting PPAR isoforms following CNS injury. Curr Drug Targets. 2013;14:733–742.
   PubMed Web of Science ®Google Scholar
• Chawla A. Control of macrophage activation and function by PPARs. Circ Res. 2010;106:1559–1569.
   PubMed Web of Science ®Google Scholar
• McTigue DM, Tripathi R, Wei P, et al. The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Exp Neurol. 2007;205:396–406.
   PubMed Web of Science ®Google Scholar
• Lourbopoulos A, Grigoriadis N, Lagoudaki R, et al. Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. Brain Res. 2011;1390:126–141.
   PubMed Web of Science ®Google Scholar
• Arevalo MA, Diz-Chaves Y, Santos-Galindo M, et al. Selective oestrogen receptor modulators decrease the inflammatory response of glial cells. J Neuroendocrinol. 2012;24:183–190.
   PubMed Web of Science ®Google Scholar
• Wu WF, Tan XJ, Dai YB, et al. Targeting estrogen receptor beta in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2013;110:3543–3548.
   PubMed Web of Science ®Google Scholar
• Hjorth E, Freund-Levi Y. Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid. Curr Opin Clin Nutr Metab Care. 2012;15:134–143.
   PubMed Web of Science ®Google Scholar
• Ohnishi M, Monda A, Takemoto R, et al. Sesamin suppresses activation of microglia and p44/42 MAPK pathway, which confers neuroprotection in rat intracerebral hemorrhage. Neuroscience. 2013;232:45–52.
   PubMed Web of Science ®Google Scholar
• Yrjanheikki J, Keinanen R, Pellikka M, et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A. 1998;95:15769–15774.
   PubMed Web of Science ®Google Scholar
• Jiang X, Ni Y, Liu T, et al. Inhibition of LPS-induced retinal microglia activation by naloxone does not prevent photoreceptor death. Inflammation. 2013;36:42–52.
   PubMed Web of Science ®Google Scholar
• Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther. 2000;293:607–617.
   PubMed Web of Science ®Google Scholar
• Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol. 2011;29:1005–1010.
   PubMed Web of Science ®Google Scholar
• Chen KB, Uchida K, Nakajima H, et al. Tumor necrosis factor-alpha antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila Pa 1976). 2011;36:1350–1358.
   PubMed Web of Science ®Google Scholar
• Fujita H, Tanaka J, Maeda N, et al. Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor. Neurosci Lett. 1998;242:37–40.
   PubMed Web of Science ®Google Scholar
• Pabon MM, Bachstetter AD, Hudson CE, et al. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease. J Neuroinflammation. 2011;8:9.
   PubMed Web of Science ®Google Scholar
• Misra S. Human gene therapy: a brief overview of the genetic revolution. J Assoc Physicians India. 2013;61:127–133.
   PubMedGoogle Scholar
• Wieghofer P, Knobeloch KP, Prinz M. Genetic targeting of microglia. Glia. 2015;63:1–22.
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Ren XL, Perides G, et al. Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors. Gene Ther. 2003;10:657–667.
   PubMed Web of Science ®Google Scholar
• Boillee S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389–1392.
   PubMed Web of Science ®Google Scholar
• Cailhier JF, Partolina M, Vuthoori S, et al. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J Immunol. 2005;174:2336–2342.
   PubMed Web of Science ®Google Scholar
• Dziennis S, Van Etten RA, Pahl HL, et al. The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood. 1995;85:319–329.
   PubMed Web of Science ®Google Scholar
• Ferron M, Vacher J. Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice. Genesis. 2005;41:138–145.
   PubMed Web of Science ®Google Scholar
• Heppner FL, Greter M, Marino D, et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med. 2005;11:146–152.
   PubMed Web of Science ®Google Scholar
• Simard AR, Soulet D, Gowing G, et al. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer’s disease. Neuron. 2006;49:489–502.
   PubMed Web of Science ®Google Scholar
• Goldmann T, Wieghofer P, Müller PF, et al. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci. 2013;16:1618–1626.
   PubMed Web of Science ®Google Scholar
• Thawer SG, Mawhinney L, Chadwick K, et al. Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model. J Neuroimmunol. 2013;261:7–20.
   PubMed Web of Science ®Google Scholar
• Jung S, Aliberti J, Graemmel P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 2000;20:4106–4114.
   PubMed Web of Science ®Google Scholar
• Wolf Y, Yona S, Kim K-W, et al. Microglia, seen from the CX3CR1 angle. Front Cell Neurosci. 2013;7:26.
   PubMed Web of Science ®Google Scholar
• Hirasawa T, Ohsawa K, Imai Y, et al. Visualization of microglia in living tissues using Iba1-EGFP transgenic mice. J Neurosci Res. 2005;81:357–362.
   PubMed Web of Science ®Google Scholar
• Biffi A, Capotondo A, Fasano S, et al. Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. J Clin Invest. 2006;116:3070–3082.
   PubMed Web of Science ®Google Scholar
• Aronovich EL, Hackett PB. Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier. Mol Genet Metab. 2015;114:83–93.
   PubMed Web of Science ®Google Scholar
• Biffi A, Montini E, Lorioli L, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341:1233158.
   PubMed Web of Science ®Google Scholar
• Li F, Zhu S, Wu C, et al. Neuroinflammation and cell therapy for Parkinson’s disease. Front Biosci (Schol Ed). 2011;3:1407–1420.
   PubMedGoogle Scholar
• Zanier ER, Pischiutta F, Riganti L, et al. Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma. Neurotherapeutics. 2014;11:679–695.
   PubMed Web of Science ®Google Scholar
• Boido M, Piras A, Valsecchi V, et al. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. Cytotherapy. 2014;16:1059–1072.
   PubMed Web of Science ®Google Scholar
• Giunti D, Parodi B, Cordano C, et al. Can we switch microglia’s phenotype to foster neuroprotection? Focus on multiple sclerosis. Immunology. 2014;141:328–339.
   PubMed Web of Science ®Google Scholar
• Liang X, Ding Y, Zhang Y, et al. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23:1045–1059.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11–15.
   PubMed Web of Science ®Google Scholar
• Giunti D, Parodi B, Usai C, et al. Mesenchymal Stem Cells Shape Microglia Effector Functions Through the Release of CX3CL1. Stem Cells. 2012;30:2044–2053.
   PubMed Web of Science ®Google Scholar
• Hamilton JA, Ting AE, Mays RW Modulation of microglia activation. US20110212069A1; 2011.
   Google Scholar
• Glenn JD, Whartenby KA. Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells. 2014;6:526–539.
   PubMedGoogle Scholar
• Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383–396.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Uchida K, Guerrero AR, et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma. 2012;29:1614–1625.
   PubMed Web of Science ®Google Scholar
• Festoff BW, Ameenuddin S, Arnold PM, et al. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem. 2006;97:1314–1326.
   PubMed Web of Science ®Google Scholar
• Papa S, Rossi F, Ferrari R, et al. Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury. ACS Nano. 2013;7:9881–9895.
   PubMed Web of Science ®Google Scholar
• Abraham J, Fox PD, Condello C, et al. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol Dis. 2012;46:425–430.
   PubMed Web of Science ®Google Scholar
• Arnold SA, Hagg T. Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice. J Neurotrauma. 2011;28:1995–2002.
   PubMed Web of Science ®Google Scholar
• Chen Y, Won SJ, Xu Y, et al. Targeting microglial activation in stroke therapy: pharmacological tools and gender effects. Curr Med Chem. 2014;21:2146–2155.
   PubMed Web of Science ®Google Scholar
• Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169:337–352.
   PubMed Web of Science ®Google Scholar
• Lee SM, Yune TY, Kim SJ, et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma. 2003;20:1017–1027.
   PubMed Web of Science ®Google Scholar
• Wells JE, Hurlbert RJ, Fehlings MG, et al. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain. 2003;126:1628–1637.
   PubMed Web of Science ®Google Scholar
• Kremlev SG, Roberts RL, Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol. 2004;149:1–9.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang H, Yang J, et al. Granulocyte colony-stimulating factor improves alternative activation of microglia under microenvironment of spinal cord injury. Neuroscience. 2013;238:1–10.
   PubMed Web of Science ®Google Scholar
• Allahtavakoli M, Shabanzadeh AP, Sadr SS, et al. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke. Clin Exp Pharmacol Physiol. 2006;33:1052–1058.
   PubMed Web of Science ®Google Scholar
• Collino M, Aragno M, Mastrocola R, et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol. 2006;530:70–80.
   PubMed Web of Science ®Google Scholar
• Esposito E, Cuzzocrea S. Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury. Expert Opin Ther Targets. 2011;15:943–959.
   PubMed Web of Science ®Google Scholar
• Kato T, Monji A, Hashioka S, et al. Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res. 2007;92:108–115.
   PubMed Web of Science ®Google Scholar
• Bian Q, Kato T, Monji A, et al. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:42–48.
   PubMed Web of Science ®Google Scholar
• Kato T, Mizoguchi Y, Monji A, et al. Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro. J Neurochem. 2008;106:815–825.
   PubMed Web of Science ®Google Scholar
• Horikawa H, Kato TA, Mizoguchi Y, et al. Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1306–1316.
   PubMed Web of Science ®Google Scholar
• O’Sullivan JB, Ryan KM, Curtin NM, et al. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol. 2009;12:687–699.
   PubMed Web of Science ®Google Scholar
• Misra A, Ganesh S, Shahiwala A, et al. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003;6:252–273.
   PubMed Web of Science ®Google Scholar
• Wang M, Etu J, Joshi S. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits. J Neurosurg Anesthesiol. 2007;19:249–256.
   PubMed Web of Science ®Google Scholar
• Emerich DF, Dean RL, Osborn C, et al. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation. Clin Pharmacokinet. 2001;40:105–123.
   PubMed Web of Science ®Google Scholar
• Rapoport SI. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell Mol Neurobiol. 2000;20:217–230.
   PubMed Web of Science ®Google Scholar
• Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev. 2008;60:1209–1217.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Recent advances in blood-brain barrier transport. Annu Rev Pharmacol Toxicol. 1988;28:25–39.
   PubMed Web of Science ®Google Scholar
• Solaro R, Chiellini F, Battisti A. Targeted delivery of protein drugs by nanocarriers. Materials. 2010;3:1928–1980.
   Web of Science ®Google Scholar
• Jain NK, Mishra V, Mehra NK. Targeted drug delivery to macrophages. Expert Opin Drug Deliv. 2013;10:353–367.
   PubMed Web of Science ®Google Scholar
• Papa S, Ferrari R, De Paola M, et al. Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury. J Control Release. 2014;174:15–26.
   PubMed Web of Science ®Google Scholar
• Caron I, Papa S, Rossi F, et al. Nanovector-mediated drug delivery for spinal cord injury treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014;6:506–515.
   PubMed Web of Science ®Google Scholar
• Rossi F, Perale G, Papa S, et al. Current options for drug delivery to the spinal cord. Expert Opin Drug Deliv. 2013;10:385–396.
   PubMed Web of Science ®Google Scholar
• Minami SS, Sun B, Popat K, et al. Selective targeting of microglia by quantum dots. J Neuroinflammation. 2012;9:22.
   PubMed Web of Science ®Google Scholar
• Cerqueira SR, Oliveira JM, Silva NA, et al. Microglia response and in vivo therapeutic potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury. Small. 2013;9:738–749.
   PubMed Web of Science ®Google Scholar
• Blume T, Doecke WD, Halfbrodt W, et al. Microglia inhibitors for interrupting interleukin 12 and ifngamma-mediated immune reactions. US20060211690A1; 2006.
   Google Scholar
• Blume T, Halfbrodt W, Kuhnke J, et al. Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases. WO200303006438A1; 2003.
   Google Scholar
• Kuhnke J, Halfbrodt W, Moenning U 1,2-diaryl benzimidazoles for treating illness associated with a microglia activation. WO20000151473A1; 2000.
   Google Scholar
• Booth R. Cathepsin enhibitors for treating microglia-mediated neuron loss in the central nervous system. WO2012174552A2; 2012.
   Google Scholar
• Scopes D, Horwell D. Pyrrolo [3,2 -E] [1,2,4] triazolo [1,5 A] pyrimidines derivatives as inhibitors of microglia activation. WO2011042497A1; 2011.
   Google Scholar
• Wang S, Hu L, Gao X, et al. Application of tanshinone I to treatment of microglia-mediated disease. CN102552236A; 2012.
   Google Scholar
• Wu HM, Hong JS, Lu RB. Memantine protects inflammation-related degeneration of dopamine neurons through inhibition of over-activated microglia and release of neurotrophic factors from astroglia. US20090118376A1; 2009.
   Google Scholar
• Rangaraju S, Gearing M, Jin LW, et al. Potassium Channel Kv1.3 Is Highly Expressed by Microglia in Human Alzheimer’s Disease. J Alzheimer’s Dis. 2015;44:797–808.
   PubMed Web of Science ®Google Scholar
• Wulff H, Jin LW, Maezawa I. The reduction of microglia-mediated neurotoxicity by kv1.3 inhibition. WO2012170917A2; 2012.
   Google Scholar
• De Silvestri F, Romani E. Use in one pill/tablet/capsule minocycline, acicloguanosin, atorvastatin and vitamin d in the treatment of theumatoid arthritis. WO2015037023A1; 2015.
   Google Scholar
• Lorenz P, Reinhold D, Goihl A, et al. Use of A-ring aromatic acetyl minocycline and pharmaceutical preparations derived from same for treatment and prevention of inflammation, autoimmune disorders and rejection of transplants. EP20122659887A1; 2012.
   Google Scholar
• Sin-Soo J, Ching-Heon R. Therapeutic agent and treatment method for multiple sclerosis through concomitant administration of human bone marrow-derived mesenchymal stem cell and minocycline. WO2014193060A1; 2014.
   Google Scholar
• Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87:10–20.
   PubMed Web of Science ®Google Scholar
• Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77–98.
   PubMed Web of Science ®Google Scholar
• Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015;1619:1–11.
   PubMed Web of Science ®Google Scholar
• Amor S, Peferoen LA, Vogel DY, et al. Inflammation in neurodegenerative diseases–an update. Immunology. 2014;142:151–166.
   PubMed Web of Science ®Google Scholar
• Tyler JY, Xu XM, Cheng JX. Nanomedicine for treating spinal cord injury. Nanoscale. 2013;5:8821–8836.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314–1318.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–419.
   PubMed Web of Science ®Google Scholar
• Cohen M, Matcovitch O, David E, et al. Chronic exposure to TGFbeta1 regulates myeloid cell inflammatory response in an IRF7-dependent manner. Embo J. 2014;33:2906–2921.
   PubMed Web of Science ®Google Scholar
• Lu W, Bhasin M, Tsirka SE. Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis. J Neurosci. 2002;22:10781–10789.
   PubMed Web of Science ®Google Scholar
• Shaked I, Porat Z, Gersner R, et al. Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J Neuroimmunol. 2004;146:84–93.
   PubMed Web of Science ®Google Scholar